Repligen Corp. buy Wolfe Research
Start price
29.04.25
/
50%
€123.75
Target price
29.04.26
€140.48
Performance (%)
-19.66%
Price
09:30
€99.32
Summary
This prediction is currently active. The price of Repligen Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.66%. This prediction currently runs until 29.04.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Repligen Corp. | 0.280% | 0.280% |
| iShares Core DAX® | -3,51 % | -8,75 % |
| iShares Nasdaq 100 | -2,78 % | -0,63 % |
| iShares Nikkei 225® | -2,04 % | -6,84 % |
| iShares S&P 500 | -2,60 % | -2,23 % |
Comments by Wolfe_Research for this prediction
In the thread Repligen Corp. diskutieren
Repligen Co. (NASDAQ: RGEN) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $160.00 price target on the stock.
Ratings data for RGEN provided by MarketBeat